Related Experiment Video
Updated: Jun 25, 2025
05:10
Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
Published on: December 11, 2016
9.6K
System biology approaches for drug repurposing
Juveriya Israr1, Shabroz Alam2, Ajay Kumar3
1Institute of Biosciences and Technology, Shri Ramswaroop Memorial University, Lucknow-Deva Road, Barabanki, Uttar Pradesh, India; Department of Biotechnology Era University, Lucknow, Uttar Pradesh, India.
Summary
Drug repurposing identifies new uses for existing drugs, saving millions in development. Systems biology accelerates this process by analyzing data for safe, effective candidates.
Area of Science:
- Pharmacology
- Computational Biology
- Drug Discovery
Background:
- Drug repurposing offers a cost-effective alternative to de novo drug development.
- Established drugs possess known safety and pharmacokinetic profiles, reducing clinical trial risks.
- Significant cost savings, estimated at $300 million per repurposed drug, drive interest in this strategy.
Purpose of the Study:
- To explore the application of systems biology methodologies in drug repurposing.
- To identify computational techniques for discovering novel therapeutic applications of existing medications.
- To leverage existing drug data for efficient identification of candidates with favorable safety profiles.
Main Methods:
- Utilizing systems biology approaches, including signature matching and network-based strategies.
- Employing computational techniques to analyze pre-existing drug-related data and databases.
- Focusing on identifying repurposed drugs with minimal or acceptable patient side effects.
Main Results:
- Systems biology facilitates the identification of viable drug repurposing candidates.
- Computational methods enable the analysis of large datasets for potential drug repositioning.
- The strategy prioritizes drugs with established safety and pharmacokinetic properties.
Conclusions:
- Systems biology significantly expedites the drug repurposing discovery process.
- Computational approaches provide novel insights for structure-based drug design.
- Drug repurposing, enhanced by systems biology, presents a promising avenue for efficient therapeutic innovation.
More Related Videos
Related Concept Videos
01:28Structure-Activity Relationships and Drug Design
699
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
699
01:26Drug Discovery: Overview
7.8K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.8K
01:16Drug Biotransformation: Overview
2.4K
Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
2.4K
01:15Model Approaches for Pharmacokinetic Data: Physiological Models
41
Physiological models in pharmacokinetics are instrumental in understanding the distribution and elimination of drugs within the body. These models describe the drug concentration within target organs, influenced by factors such as drug uptake, tissue volume, and blood flow. Drug uptake is governed by the partition coefficient, which signifies the drug concentration ratio in tissue to that in the blood. The blood flow rate to a specific tissue is expressed as Qt, and the rate of change in tissue...
41
01:24Principles of Drug Action
6.0K
Drugs are chemical substances that modify biological responses by interacting with macromolecular targets such as receptors, ion channels, transporters, and enzymes. Pharmacodynamics describes the course of action of drugs leading to the physiological effect at a specific site in the body.
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
6.0K
01:26Pharmacokinetic Models: Comparison and Selection Criterion
69
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
69